170 related articles for article (PubMed ID: 12202121)
1. Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology.
Dragomir AD; Kraus VB; Renner JB; Luta G; Clark A; Vilim V; Hochberg MC; Helmick CG; Jordan JM
Osteoarthritis Cartilage; 2002 Sep; 10(9):687-91. PubMed ID: 12202121
[TBL] [Abstract][Full Text] [Related]
2. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.
Clark AG; Jordan JM; Vilim V; Renner JB; Dragomir AD; Luta G; Kraus VB
Arthritis Rheum; 1999 Nov; 42(11):2356-64. PubMed ID: 10555031
[TBL] [Abstract][Full Text] [Related]
3. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project.
Jordan JM; Luta G; Stabler T; Renner JB; Dragomir AD; Vilim V; Hochberg MC; Helmick CG; Kraus VB
Arthritis Rheum; 2003 Mar; 48(3):675-81. PubMed ID: 12632420
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis.
Vilím V; Olejárová M; Machácek S; Gatterová J; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2002 Sep; 10(9):707-13. PubMed ID: 12202123
[TBL] [Abstract][Full Text] [Related]
5. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
[TBL] [Abstract][Full Text] [Related]
6. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
Fernandes FA; Pucinelli ML; da Silva NP; Feldman D
Scand J Rheumatol; 2007; 36(3):211-5. PubMed ID: 17657676
[TBL] [Abstract][Full Text] [Related]
7. Protein modification by deamidation indicates variations in joint extracellular matrix turnover.
Catterall JB; Hsueh MF; Stabler TV; McCudden CR; Bolognesi M; Zura R; Jordan JM; Renner JB; Feng S; Kraus VB
J Biol Chem; 2012 Feb; 287(7):4640-51. PubMed ID: 22179616
[TBL] [Abstract][Full Text] [Related]
8. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker.
Verma P; Dalal K
J Orthop Res; 2013 Jul; 31(7):999-1006. PubMed ID: 23423905
[TBL] [Abstract][Full Text] [Related]
9. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of incident radiographic knee osteoarthritis: do they vary by chronic knee symptoms?
Golightly YM; Marshall SW; Kraus VB; Renner JB; Villaveces A; Casteel C; Jordan JM
Arthritis Rheum; 2011 Aug; 63(8):2276-83. PubMed ID: 21506100
[TBL] [Abstract][Full Text] [Related]
11. Associations between suprapatellar pouch effusion-synovitis, serum cartilage oligomeric matrix protein, high sensitivity C-reaction protein, knee symptom, and joint structural changes in patients with knee osteoarthritis.
Yang X; Ruan G; Xu J; Zheng S; Wang K; Ding C
Clin Rheumatol; 2020 May; 39(5):1663-1670. PubMed ID: 31897961
[TBL] [Abstract][Full Text] [Related]
12. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
Wisłowska M; Jabłońska B
Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
[TBL] [Abstract][Full Text] [Related]
13. [Serum levels of cartilage oligomeric matrix protein in the diagnosis of knee osteoarthritis].
Li H; Wang D; Wu ZQ; Zhong JM; Yuan YJ
Zhongguo Gu Shang; 2012 May; 25(5):380-3. PubMed ID: 22870681
[TBL] [Abstract][Full Text] [Related]
14. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
[TBL] [Abstract][Full Text] [Related]
15. The heritable determinants of cartilage oligomeric matrix protein.
Williams FM; Andrew T; Saxne T; Heinegard D; Spector TD; MacGregor AJ
Arthritis Rheum; 2006 Jul; 54(7):2147-51. PubMed ID: 16802351
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint.
Sharif M; Saxne T; Shepstone L; Kirwan JR; Elson CJ; Heinegård D; Dieppe PA
Br J Rheumatol; 1995 Apr; 34(4):306-10. PubMed ID: 7788143
[TBL] [Abstract][Full Text] [Related]
17. A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 years.
Erhart-Hledik JC; Favre J; Asay JL; Smith RL; Giori NJ; Mündermann A; Andriacchi TP
Osteoarthritis Cartilage; 2012 Nov; 20(11):1309-15. PubMed ID: 22868052
[TBL] [Abstract][Full Text] [Related]
18. Inverse association of general joint hypermobility with hand and knee osteoarthritis and serum cartilage oligomeric matrix protein levels.
Chen HC; Shah SH; Li YJ; Stabler TV; Jordan JM; Kraus VB
Arthritis Rheum; 2008 Dec; 58(12):3854-64. PubMed ID: 19035482
[TBL] [Abstract][Full Text] [Related]
19. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation.
Addison S; Coleman RE; Feng S; McDaniel G; Kraus VB
Arthritis Rheum; 2009 Nov; 60(11):3366-73. PubMed ID: 19877068
[TBL] [Abstract][Full Text] [Related]
20. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
Wisłowska M; Jabłońska B
Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]